Daicel Corp - Company Profile
Powered by 
All the sales intelligence you need on Daicel Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Daicel Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Daicel Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Daicel Corp (Daicel) is a chemical manufacturing company focused on providing solutions that address social needs through its diverse range of products and services. The company's main activities include research and development in healthcare, electronics, safety systems, and materials. Daicel's major products encompass high-quality raw materials for cosmetics, pharmaceutical development solutions, functional films, polymers, solvents, and safety systems like automobile airbag inflators. Notable brands associated with Daicel include Actranza Lab and Bellocea S7. The company's products serve customers across various industries, including healthcare, electronics, automotive, and environmental sectors. It operates through a network of channel partners and distribution networks to reach its target markets. Daicel is headquartered in Osaka, Japan.
Headquarters
Japan
Address
3-1, Ofuka-cho, Grand Front Osaka Tower-B, Kita, 530-0011
Website
www.daicel.com
Telephone
81 6 76397171
No of Employees
11,178
Industry
Chemicals
Ticker Symbol & Exchange
4202 (TYO)
Revenue (2025)
$4.1B
5.1%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-11.4%
(2025 vs 2024)
Market Cap*
$2.2B
Net Profit Margin (2025)
XYZ
-15.7%
(2025 vs 2024)
* As of and is in US$
Daicel Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Cellulosic Derivatives: | - |
| Cellulose Acetate | Diannovare |
| Acetate Tow | Bellocea |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In March, the company entered into an agreement to sell a 15% stake in Toyo Styrene to Denka Company Limited, a chemical fertilizer company. |
| 2026 | Plans/Strategy | In January, Polyplastics ‑ Evonik announced its plans to change its corporate name to Daicel ‑ Evonik Corporation. |
| 2025 | Regulatory Approval | In November, Daicel Medical Ltd. secured PMDA approval for its gas-powered Needle-free Injector, Daicel Injector P1 SC, in Japan. |
Competitor Comparison
| Key Parameters | Daicel Corp | Mitsubishi Chemical Corp | Sumitomo Chemical Co Ltd | Toray Industries Inc | Zeon Corp |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Kita | Chiyoda-ku | Chuo-Ku | Chuo-Ku | Chiyoda-Ku |
| State/Province | Osaka | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 11,178 | 38,589 | 29,279 | 47,914 | 4,493 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yoshimi Ogawa | Chairman; Director | Executive Board | 2025 | 66 |
| Yasuhiro Sakaki | Chief Executive Officer; Head of Corporate Planning & Strategy Office; Head of Healthcare SBU; President | Executive Board | 2025 | 64 |
| Kotaro Sugimoto | Director; General Manager - Corporate Support Headquarters; Head - Corporate Compliance Program; Head - Corporate Sustainability; Head - Digital Strategy Division; Senior Managing Executive Officer | Executive Board | 2020 | 66 |
| Toshio Shiwaku | Director; General Manager - Assessment Headquarters; General Manager - R&D Headquarters; Senior Managing Executive Officer | Executive Board | 2024 | 63 |
| Naotaka Kawaguchi | Director; General Manager - Production Management Headquarters; Head - Engineering Center; Head - Safety and Quality Assurance Headquarters; Head - Safety SBU; Senior Managing Executive Officer | Senior Management | 2024 | 65 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer